Description
RADIUM-223 DICHLORIDE (XOFIGO) DELIVERY TO PITTSBURGH VAMC NUCLEAR MEDICINE FOR PATIENT CARE POP 10/1/2018-1/03/2020
Base award description: RADIUM-223 DICHLORIDE (XOFIGO) DELIVERY TO PITTSBURGH VAMC NUCLEAR MEDICINE FOR PATIENT CARE
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$181,924= $181,924
- Mod P000012019-12-20+$0= $181,924
- Mod P000022021-01-22-$8,591= $173,333
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$181,924 | $181,924 | RADIUM-223 DICHLORIDE (XOFIGO) DELIVERY TO PITTSBURGH VAMC NUCLEAR MEDICINE FOR PATIENT CARE |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2019-12-20 | +$0 | $181,924 | RADIUM-223 DICHLORIDE (XOFIGO) DELIVERY TO PITTSBURGH VAMC NUCLEAR MEDICINE FOR PATIENT CARE POP 10/1/2018-1/0… |
| Mod P00002· FUNDING ONLY ACTION | 2021-01-22 | −$8,591 | $173,333 | RADIUM-223 DICHLORIDE (XOFIGO) DELIVERY TO PITTSBURGH VAMC NUCLEAR MEDICINE FOR PATIENT CARE POP 10/1/2018-1/0… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q527 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24425P0005 | JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $140,905 | FY2025 |
| 36C24420C0118 | CDL NUCLEAR TECHNOLOGIES, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $0 | FY2020 |
| VA24416C0167 | TRIAD ISOTOPES, INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $196,400 | FY2016 |
| VA24415P0041 | SOFIE CO. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $66,125 | FY2015 |
| VA24414F2302 | CHG COMPANIES, INC. | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $285,475 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24420F0046_3600_36C24418D0233_3600 · retrieved 2026-09-26.